Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Hilmi Sari"'
Autor:
Serdar Celik, Ozde Gokbayrak, Aylin Erol, Kutsal Yorukoglu, Tekincan Aktas, Hilmi Sari, Batuhan Yilmaz, Mehmet Ugur Mungan, Guven Aslan, Ilhan Celebi, Zekiye Altun, Tugba Yavuzsen, Safiye Aktas
Publikováno v:
Personalized Medicine.
Aim: To evaluate the ex vivo efficacy of chemotherapy, immunotherapy and targeted agents with the oncogram method in patients with bladder cancer and determine the most appropriate personalized treatment agent using immune markers. Materials & method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7fac17880a7848c419b0a58e8286639
https://doi.org/10.2217/pme-2022-0134
https://doi.org/10.2217/pme-2022-0134
Autor:
Serdar, Celik, Hilmi, Sari, Mehmet, Ugur Mungan, Kutsal, Yorukoglu, Ilhan, Celebi, Safiye, Aktas
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(1)
To investigate the ex-vivo efficacy of immunotherapeutics and chemotherapeutics in bladder cancer primary cell cultures, to assess the applicability of the method according to the results and to evaluate suitability of the oncogram method for persona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::16c05ab3a7bb98b1eff74c20f135f866
https://pubmed.ncbi.nlm.nih.gov/32277645
https://pubmed.ncbi.nlm.nih.gov/32277645
Autor:
HILMI, ENDANG, SARI, LILIK KARTIKA, SIREGAR, ASRUL SAHRI, SULISTYO, ISDY, MAHDIANA, ARIF, JUNAIDI, TEUKU, MUSLIH, CAHYANING PERTIWI, RIKA PRIHATI, SAMUDRA, SESILIA RANI, PRAYOGO, NORMAN ARIE
Publikováno v:
Biodiversitas: Journal of Biological Diversity; Aug2021, Vol. 22 Issue 8, p3508-3516, 9p
Autor:
HILMI, ENDANG, SARI, LILIK KARTIKA, CAHYO, TRI NUR, MUSLIH, MAHDIANA, ARIF, SAMUDRA, SESILIA RANI
Publikováno v:
Biodiversitas: Journal of Biological Diversity; Jul2021, Vol. 22 Issue 7, p2907-2918, 12p
Publikováno v:
Pain & Central Nervous System Week; 2024, p791-791, 1p
Autor:
شلال علي خلف
Publikováno v:
Journal of Al-Frahids Arts; 2019, Vol. 11 Issue 38, Part 1, p366-397, 32p
Autor:
Cigdem Pala, Mehmet Hilmi Dogu, Yusuf Bilen, Ismail Sari, Ismet Aydogdu, Cengiz Demir, Irfan Kuku, Ilhami Berber, Serdal Korkmaz, Mehmet Sinan Dal, Olga Meltem Akay, Emin Kaya, Mehmet Şencan, Fevzi Altuntaş, Mehmet Ali Erkurt, Emre Tekgündüz, Mehmet Yilmaz
WOS: 000374614700015
PubMed ID: 26810141
We investigated the course of 54 patients presenting with primary central nervous system lymphoma, who were treated in daily practice. The patients were treated with chemotherapy and/or radiotherapy
PubMed ID: 26810141
We investigated the course of 54 patients presenting with primary central nervous system lymphoma, who were treated in daily practice. The patients were treated with chemotherapy and/or radiotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f9d187112f4061bff65ee36e823bff4
https://avesis.yyu.edu.tr/publication/details/0e02812a-f0d6-4f68-b448-158cff699d3a/oai
https://avesis.yyu.edu.tr/publication/details/0e02812a-f0d6-4f68-b448-158cff699d3a/oai
Autor:
Fevzi Altuntaş, Leylagül Kaynar, Ismail Sari, Mehmet Şencan, Mehmet Ali Erkurt, Muzaffer Keklik, Serdar Sivgin, Serdal Korkmaz, Ali Keskin, Osman Ilhan, Hatice Terzi, Gulsum Akgun Cagliyan, Mehmet Hilmi Dogu
WOS: 000370676300112
…
…
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1fe7c472006c8bff459a2cc4515f9dc
https://hdl.handle.net/20.500.12418/7817
https://hdl.handle.net/20.500.12418/7817
Autor:
Ilhami BERBER, Erkurt, Mehmet Ali, Keklik, Muzaffer, Dogu, Mehmet Hilmi, Terzi, Hatice, Pala, Cigdem, Sari, Hakan Ismail, Sencan, Mehmet, Sivgin, Serdar, Hacioglu, Sibel, Altuntas, Fevzi, Aydogdu, Ismet, Ilhan, Osman
Publikováno v:
Scopus-Elsevier
Web of Science
Web of Science
WOS: 000375337000011
Introduction: During the last three decades, major advances have been made in the therapy of Hodgkin's lymphoma. However, despite these advances, Hodgkin's lymphoma has a poor prognosis in the elderly. The proportion of Hodg
Introduction: During the last three decades, major advances have been made in the therapy of Hodgkin's lymphoma. However, despite these advances, Hodgkin's lymphoma has a poor prognosis in the elderly. The proportion of Hodg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1c8d0a7a10496281657cfb7969922bc9
https://hdl.handle.net/20.500.12418/7980
https://hdl.handle.net/20.500.12418/7980
Autor:
Leylagül Kaynar, Mustafa Karagülle, Fevzi Altuntaş, Osman Ilhan, Sinan Dal, Ramazan Esen, Güray Saydam, Serdal Korkmaz, Rahsan Yildirim, Meltem Olga Akay, Melda Cömert, Mehmet Hilmi Dogu, Gulsah Akyol, Ali Ünal, Mehmet Ali Erkurt, Ismail Sari, Anil Tombak, İlhami Kiki, Erdal Kara, Naci Tiftik, Orhan Ayyildiz, Emin Kaya, Mehmet Şencan, Mehmet Ali Sungur
Publikováno v:
ResearcherID
56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA
WOS: 000349233802125
…
Amer Soc Hematol
WOS: 000349233802125
…
Amer Soc Hematol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5c620027aa59f7c68608a20e9b3d9a4
https://hdl.handle.net/11454/49399
https://hdl.handle.net/11454/49399